Andrew Serafin

HRMY

Andrew Serafin serves as CHIEF STRATEGY OFFICER at Harmony Biosciences Holdings, Inc. (HRMY). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$2.37M

Net Position

Net Seller

$2.37M

Companies Traded

HRMY

Active Period

Dec 2022 – Jan 2026

2 total trades

Most Recent

Sell HRMY

Jan 22, 2026 · $82.6K

Andrew Serafin's Insider Trading at Harmony Biosciences Holdings, Inc. (HRMY)

Buys

0 · $0.00

Sells

2 · $2.37M

Total Shares Bought

Total Shares Sold

40,242

HRMY Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 22, 2026↗	Sell	2,242	$36.82	$82.6K	0
Dec 5, 2022↗	Sell	38,000	$60.13	$2.29M	920

Related Insiders

Sandip Kapadia

CHIEF FINANCIAL OFFICER

HRMYSell · Jan 26, 2026

Sandip Kapadia

officer: CHIEF FINANCIAL OFFICER

HRMYSell · Jan 26, 2026

Kumar Budur

CHIEF MEDICAL OFFICER

HRMYSell · Jan 25, 2026

Jeffrey M. Dayno

PRESIDENT, CEO

HRMYSell · Jan 25, 2026

Explore More Insider Trading Data

HRMY Insider Trading Activity

View all insider trades at Harmony Biosciences Holdings, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity